Entity type
Company
Filer Snapshot
Satsuma Pharmaceuticals, Inc.
CIK 0001692830. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.
Total filings
19
Latest filing
08 Jun 2023
Industry
Pharmaceutical Preparations
Filing-backed research brief
Start with the SEC data that changes for this CIK
Latest signal: SEC filing timeline only. Each card links back to the PortfolioSavvy page where the filing evidence is closest.
Latest 13F portfolio
—
No parsed 13F portfolio row yet.
Browse latest 13FLargest parsed holding
—
Populates from the latest parsed 13F information table.
Open holding13D/G large stake
—
No recent parsed 13D/G stake row for this CIK.
Browse 13D/GInsider / owner context
—
No parsed Forms 3/4/5 owner position for this CIK.
Browse insider filingsSave this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Source: SEC Forms 3/4/5
View source filing
4 filed on 08 Jun 2023 for CIK 0001692830.
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 4819 Emperor Boulevard, Suite 340, Durham, NC, 27703
- Incorporated in
- DE
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields
EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 2 profile fields available
Filer intelligence
What SEC filings say about Satsuma Pharmaceuticals, Inc.
A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.
SEC source mix
Counts show available parsed rows, not one combined ownership total.
13F portfolio
No rows yet
Quarterly institutional portfolio holdings.
13D/G stakes
No rows yet
Beneficial ownership and large-stake disclosures.
Forms 3/4/5
No rows yet
Officer, director, and 10% owner holdings or transactions.
No parsed ownership summary yet
We still show the SEC filing timeline below. The intelligence summary will populate when parsed 13F, 13D/G, or Forms 3/4/5 data exists for this CIK.
SEC filing record
CIK 0001692830 filing coverage
Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.
SEC filings
19
First seen
12 Oct 2021
Latest filing
08 Jun 2023
Entity
Company
Observed form types
3
4
Industry context: Pharmaceutical Preparations.
Latest Filings
Showing the latest 12 of 19 SEC filings for Satsuma Pharmaceuticals, Inc..
4
4 filing
- Filing date
- 08 Jun 2023
- Reporting date
- 08 Jun 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 08 Jun 2023
- Reporting date
- 08 Jun 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 16 Nov 2022
- Reporting date
- 14 Nov 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 07 Jun 2022
- Reporting date
- 03 Jun 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 07 Jun 2022
- Reporting date
- 03 Jun 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 29 Nov 2021
- Reporting date
- 24 Nov 2021
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 23 Nov 2021
- Reporting date
- 19 Nov 2021
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 12 Nov 2021
- Reporting date
- 10 Nov 2021
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 10 Nov 2021
- Reporting date
- 08 Nov 2021
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 08 Nov 2021
- Reporting date
- 04 Nov 2021
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 04 Nov 2021
- Reporting date
- 02 Nov 2021
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 02 Nov 2021
- Reporting date
- 29 Oct 2021
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing